Current role of endovascular therapy in Marfan patients with previous aortic surgery
Ibrahim Akin, Stephan Kische, Tim C Rehders, Tushar Chatterjee, Henrik Schneider, Thomas Körber, Christoph A Nienaber, Hüseyin InceDepartment of Medicine, Division of Cardiology at the University Hospital Rostock, Rostock School of Medicine, Ernst-Heydemann-Str. 6, 18057 Rostock, G...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2008-02-01
|
| Series: | Vascular Health and Risk Management |
| Online Access: | https://www.dovepress.com/current-role-of-endovascular-therapy-in-marfan-patients-with-previous--peer-reviewed-article-VHRM |
| _version_ | 1818367432952119296 |
|---|---|
| author | Ibrahim Akin Stephan Kische Tim C Rehders Tushar Chatterjee Henrik Schneider et al |
| author_facet | Ibrahim Akin Stephan Kische Tim C Rehders Tushar Chatterjee Henrik Schneider et al |
| author_sort | Ibrahim Akin |
| collection | DOAJ |
| description | Ibrahim Akin, Stephan Kische, Tim C Rehders, Tushar Chatterjee, Henrik Schneider, Thomas Körber, Christoph A Nienaber, Hüseyin InceDepartment of Medicine, Division of Cardiology at the University Hospital Rostock, Rostock School of Medicine, Ernst-Heydemann-Str. 6, 18057 Rostock, GermanyAbstract: The Marfan syndrome is a heritable disorder of the connective tissue which affects the cardiovascular, ocular, and skeletal system. The cardiovascular manifestation with aortic root dilatation, aortic valve regurgitation, and aortic dissection has a prevalence of 60% to 90% and determines the premature death of these patients. Thirty-four percent of the patients with Marfan syndrome will have serious cardiovascular complications requiring surgery in the first 10 years after diagnosis. Before aortic surgery became available, the majority of the patients died by the age of 32 years. Introduction in the aortic surgery techniques caused an increase of the 10 year survival rate up to 97%. The purpose of this article is to give an overview about the feasibility and outcome of stent-graft placement in the descending thoracic aorta in Marfan patients with previous aortic surgery.Keywords: Marfan syndrome, aortic dissection, root replacement, stent-graft, previous aortic surgery |
| first_indexed | 2024-12-13T22:51:58Z |
| format | Article |
| id | doaj.art-1ce0c3db5cf24a908d75371dec77d5d0 |
| institution | Directory Open Access Journal |
| issn | 1178-2048 |
| language | English |
| last_indexed | 2024-12-13T22:51:58Z |
| publishDate | 2008-02-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Vascular Health and Risk Management |
| spelling | doaj.art-1ce0c3db5cf24a908d75371dec77d5d02022-12-21T23:28:35ZengDove Medical PressVascular Health and Risk Management1178-20482008-02-01Volume 459661593Current role of endovascular therapy in Marfan patients with previous aortic surgeryIbrahim AkinStephan KischeTim C RehdersTushar ChatterjeeHenrik Schneideret alIbrahim Akin, Stephan Kische, Tim C Rehders, Tushar Chatterjee, Henrik Schneider, Thomas Körber, Christoph A Nienaber, Hüseyin InceDepartment of Medicine, Division of Cardiology at the University Hospital Rostock, Rostock School of Medicine, Ernst-Heydemann-Str. 6, 18057 Rostock, GermanyAbstract: The Marfan syndrome is a heritable disorder of the connective tissue which affects the cardiovascular, ocular, and skeletal system. The cardiovascular manifestation with aortic root dilatation, aortic valve regurgitation, and aortic dissection has a prevalence of 60% to 90% and determines the premature death of these patients. Thirty-four percent of the patients with Marfan syndrome will have serious cardiovascular complications requiring surgery in the first 10 years after diagnosis. Before aortic surgery became available, the majority of the patients died by the age of 32 years. Introduction in the aortic surgery techniques caused an increase of the 10 year survival rate up to 97%. The purpose of this article is to give an overview about the feasibility and outcome of stent-graft placement in the descending thoracic aorta in Marfan patients with previous aortic surgery.Keywords: Marfan syndrome, aortic dissection, root replacement, stent-graft, previous aortic surgeryhttps://www.dovepress.com/current-role-of-endovascular-therapy-in-marfan-patients-with-previous--peer-reviewed-article-VHRM |
| spellingShingle | Ibrahim Akin Stephan Kische Tim C Rehders Tushar Chatterjee Henrik Schneider et al Current role of endovascular therapy in Marfan patients with previous aortic surgery Vascular Health and Risk Management |
| title | Current role of endovascular therapy in Marfan patients with previous aortic surgery |
| title_full | Current role of endovascular therapy in Marfan patients with previous aortic surgery |
| title_fullStr | Current role of endovascular therapy in Marfan patients with previous aortic surgery |
| title_full_unstemmed | Current role of endovascular therapy in Marfan patients with previous aortic surgery |
| title_short | Current role of endovascular therapy in Marfan patients with previous aortic surgery |
| title_sort | current role of endovascular therapy in marfan patients with previous aortic surgery |
| url | https://www.dovepress.com/current-role-of-endovascular-therapy-in-marfan-patients-with-previous--peer-reviewed-article-VHRM |
| work_keys_str_mv | AT ibrahimakin currentroleofendovasculartherapyinmarfanpatientswithpreviousaorticsurgery AT stephankische currentroleofendovasculartherapyinmarfanpatientswithpreviousaorticsurgery AT timcrehders currentroleofendovasculartherapyinmarfanpatientswithpreviousaorticsurgery AT tusharchatterjee currentroleofendovasculartherapyinmarfanpatientswithpreviousaorticsurgery AT henrikschneider currentroleofendovasculartherapyinmarfanpatientswithpreviousaorticsurgery AT etal currentroleofendovasculartherapyinmarfanpatientswithpreviousaorticsurgery |